Screening policies for cytomegalovirus in pregnancy in the era of antivirals

Lancet. 2022 Aug 13;400(10351):489-490. doi: 10.1016/S0140-6736(22)01299-5.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use
  • Cytomegalovirus Infections* / diagnosis
  • Cytomegalovirus Infections* / drug therapy
  • Cytomegalovirus*
  • Female
  • Humans
  • Mass Screening
  • Policy
  • Pregnancy

Substances

  • Antiviral Agents